SESSION 3: Chronic Lymphocytic Leukemia
Tracks
Main Session Hall
| Friday, May 16, 2025 |
| 2:35 PM - 4:30 PM |
Speaker
Dr. Kostas Stamatopoulos
Hematology Specialist / Director
Institute of Applied Biosciences at CERTH
Advances in Combination Therapies / Triplet Therapy and BCL2 and BTK Inhibitor Combinations
2:10 PM - 2:40 PM
Afaf Al Battah
Consultant Hematologist
NCCCR- Hamad Medical Corporation
the safety of Novel Therapies in CLL in the Era of Intermittent Fasting.
2:40 PM - 2:55 PM
Prof. Salem Al Shemmari
Consultant Hematologist
Kuwait Cancer Control Center
Kuwait Experience in CLL
2:55 PM - 3:20 PM
Dr. Nabeel Qasem
Hematology Fellow
National Center for Cancer Care & Research (NCCCR)
Chronic Lymphocytic Leukemia Presenting with Tonsillar Involvement: A Rare Manifestation and Clinical Implications
3:50 PM - 4:05 PMSession Chair
Hani Osman
Consultant Hematologist
Tawam Hospital
